Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,830 | -3,134 | -12,838 | -10,486 | -9,707 |
| Depreciation Amortization | 802 | 97 | 374 | 278 | 185 |
| Income taxes - deferred | N/A | N/A | -1,302 | -1,302 | -1,302 |
| Other Working Capital | 204 | -700 | -457 | -225 | 340 |
| Other Operating Activity | 6,412 | 201 | 5,031 | 4,912 | 4,254 |
| Operating Cash Flow | $-5,412 | $-3,536 | $-9,192 | $-6,823 | $-6,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -264 | N/A | -58 | -40 | -7 |
| Purchase Of Investment | -3,392 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 13,016 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $9,360 | $N/A | $-58 | $-40 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -815 | -510 | -205 |
| Common Stock Issued | N/A | 6,610 | 9,486 | 9,387 | 9,693 |
| Financing Cash Flow | $N/A | $6,610 | $8,671 | $8,877 | $9,488 |
| Beginning Cash Position | 12,276 | 5,132 | 5,711 | 5,711 | 5,711 |
| End Cash Position | 16,224 | 8,206 | 5,132 | 7,725 | 8,962 |
| Net Cash Flow | $3,948 | $3,074 | $-579 | $2,014 | $3,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,412 | -3,536 | -9,192 | -6,823 | -6,230 |
| Capital Expenditure | -329 | N/A | -58 | -40 | -7 |
| Free Cash Flow | -5,741 | -3,536 | -9,250 | -6,863 | -6,237 |